Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지
DOI QR코드

DOI QR Code

Evaluation of the 7th UICC TNM Staging System of Gastric Cancer

  • Kwon, Sung-Joon (Department of Surgery, Hanyang University College of Medicine)
  • Received : 2011.03.23
  • Accepted : 2011.04.30
  • Published : 2011.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Since January of 2010, the seventh edition of UICC tumor node metastasis (TNM) Classification, which has recently been revised, has been applied to almost all cases of malignant tumors. Compared to previous editions, the merits and demerits of the current revisions were analyzed. Many revisions have been made for criteria for the classification of lymph nodes. In particular, all the cases in whom the number of lymph nodes is more than 7 were classified as N3 without being differentiated. Therefore, the coverage of the N3 was broad. Owing to this, there was no consistency in predicting the prognosis of the N3 group. By determining the positive cases to a distant metastasis as TNM stage IV, the discrepancy in the TNM stage IV compared to the sixth edition was resolved. In regard to the classification system for an esophagogastric (EG) junction carcinoma, it was declared that cases of an invasion to the EG junction should follow the classification system for esophageal cancer. A review of clinical cases reported from Asian patients suggests that it would be more appropriate to follow the previous editions of the classification system for gastric cancer. In addition, in the classification of the TNM stages in the overall cases, the discrepancy in the prognosis between the different stages and the consistency in the prognosis between the same TNM stages were achieved to a lesser extent as compared to that previously. Accordingly, further revisions are needed to develop a purposive classification method where the prognosis can be predicted specifically to each variable and the mode of the overall classification can be simplified.

Keywords

References

  1. Sayegh ME, Sano T, Dexter S, Katai H, Fukagawa T, Sasako M. TNM and Japanese staging systems for gastric cancer: how do they coexist? Gastric Cancer 2004;7:140-148.
  2. Ha TK, Kim HJ, Kwon SJ. Does the New UICC/AJCC TNM Staging System (7th Edition) Improve Assessing Prognosis in Gastric Cancer Compared to the Old System (6th Edition)? J Korean Gastric Cancer Assoc 2009;9:159-166.
  3. Huang B, Zheng X, Wang Z, Wang M, Dong Y, Zhao B, et al. Prognostic significance of the number of metastatic lymph nodes: is UICC/TNM node classification perfectly suitable for early gastric cancer? Ann Surg Oncol 2009;16:61-67. https://doi.org/10.1245/s10434-008-0193-7
  4. Qiu MZ, Wang ZQ, Zhang DS, Liu Q, Luo HY, Zhou ZW, et al. Comparison of 6th and 7th AJCC TNM staging classification for carcinoma of the stomach in China. Ann Surg Oncol 2011 Jan 19. [Epub ahead of print]
  5. Deng J, Liang H, Sun D, Wang D, Pan Y. Suitability of 7th UICC N stage for predicting the overall survival of gastric cancer patients after curative resection in China. Ann Surg Oncol 2010;17:1259-1266. https://doi.org/10.1245/s10434-010-0939-x
  6. Deng J, Liang H, Wang D. The feasibility of N stage of the 7th edition TNM for gastric cancer. Ann Surg Oncol 2011;18:1805- 1806. https://doi.org/10.1245/s10434-010-1348-x
  7. Bae JM, Kim SW, Kim SW, Song SK. Evaluation of prognostic values according to the new TNM classification in gastric cancer. J Korean Surg Soc 2011;80:23-28. https://doi.org/10.4174/jkss.2011.80.1.23
  8. Deng JY, Liang H, Sun D, Zhan HJ, Wang XN, The appropriate cutoffs of positive lymph nodes to evaluate the prognosis of gastric cancer patients. J Surg Oncol 2008;98:343-348. https://doi.org/10.1002/jso.21119
  9. Bunt AM, Hermans J, Smit VT, van de Velde CJ, Fleuren GJ, Bruijn JA. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 1995;13:19-25. https://doi.org/10.1200/JCO.1995.13.1.19
  10. Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: fifth edition American Joint Committee on Cancer staging, proximal disease, and the ''different disease'' hypothesis. Cancer 2000;88:921-932. https://doi.org/10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.0.CO;2-S
  11. Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, et al. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surgl Oncol 2006;14:306-316.
  12. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725- 730. https://doi.org/10.1056/NEJMoa010187
  13. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20. https://doi.org/10.1056/NEJMoa055531
  14. Strong VE, Song KY, Park CH, Jacks LM, Gonen M, Shah M, et al. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg 2010;251:640-646. https://doi.org/10.1097/SLA.0b013e3181d3d29b
  15. Fukuda N, Sugiyama Y, Midorikawa A, Mushiake H. Prognostic significance of the metastatic lymph node ratio in gastric cancer patients. World J Surg 2009;33:2378-2382. https://doi.org/10.1007/s00268-009-0205-1
  16. Persiani R, Rausei S, Biondi A, Boccia S, Cananzi F, D'Ugo D. Ratio of metastatic lymph nodes: impact on staging and survival of gastic cancer. Eur J Surg Oncol 2008;34:519-524. https://doi.org/10.1016/j.ejso.2007.05.009
  17. Marchet A, Mocellin S, Ambrosi A, Morgagni P, Garcea D, Marrelli D, et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 2007;245:543-552. https://doi.org/10.1097/01.sla.0000250423.43436.e1
  18. Moug SJ, Saldanha JD, McGregor JR, Balsitis M, Diament RH. Positive lymph node retrieval ratio optimizes patient staging in colorectal cancer. Br J Cancer 2009;100:1530-1533. https://doi.org/10.1038/sj.bjc.6605049
  19. Peschaud F, Benoist S, Julie C, Beauchet A, Penna C, Rougier P, et al. The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer. Ann Surg 2008;248:1067-1073. https://doi.org/10.1097/SLA.0b013e31818842ec
  20. Van der Wal BC, Butzelaar RM, van der Meij S, Boermeeste MA. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer. Eur J Surg Oncol 2002;28:481-489. https://doi.org/10.1053/ejso.2002.1239
  21. Lemmens VE, Dassen AE, van der Wurff AA, Coebergh JW, Bosscha K. Lymph node examination among patients with gastric cancer: Variation between department of pathology and prognostic impact of lymph node ratio. Eur J Surg Oncol 2011;37:488-496. https://doi.org/10.1016/j.ejso.2011.03.005
  22. Ha TK, Kwon SJ. Subclassification of stage IV gastric cancer according to the presence of distant metastasis (IVa and IVb). J Korean Gastric Cancer Assoc 2006;6:173-180. https://doi.org/10.5230/jkgca.2006.6.3.173
  23. Park JM, Park SS, Mok YJ, Kim CS. pN3M0 gastric cancer: the category that allows the sub-classification of stage IV gastric cancer (IVa and IVb). Ann Surg Oncol 2007;14:2535-2542. https://doi.org/10.1245/s10434-007-9445-1
  24. Li C, Yan M, Chen J, Xiang M, Zhu ZG, Lin YZ. Prognostic influence of sub-stages according to pTNM categories in patients with stage IV gastric cancer. J Surg Oncol 2009;99:324-328. https://doi.org/10.1002/jso.21242
  25. An JY, Ha TK, Noh JH, Sohn TS, Kim S. Proposal to subclassify stage IV gastric cancer into IVa, IVb, and IVM. Arch Surg 2009;144:38-45. https://doi.org/10.1001/archsurg.2008.502
  26. Kodera Y, Nakanishi H, Ito S, Nakao A. Clinical significance of isolated tumor cells and micrometastases in patients with gastric carcinoma. Gan To Kagaku Ryoho 2007;34:817-823.
  27. Fukagawa T, Katai H, Saka M, Morita S, Sasajima Y, Taniguchi H, et al. Significance of lavage cytology in advanced gastric cancer patients. World J Surg 2010;34:563-568. https://doi.org/10.1007/s00268-009-0355-1
  28. Badgwell B, Cormier JN, Krishnan S, Yao J, Staerkel GA, Lupo PJ, et al. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? Ann Surg Oncol 2008;15:2684-2691. https://doi.org/10.1245/s10434-008-0055-3
  29. Nath J, Moorthy K, Taniere P, Hallissey M, Alderson D. Peritoneal lavage cytology in patients with oesophagogastric adenocarcinoma. Br J Surg 2008;95:721-726. https://doi.org/10.1002/bjs.6107
  30. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg 2010;17:3077-3079. https://doi.org/10.1245/s10434-010-1362-z
  31. Hassan HA, Sharma VK, Raufman JP. Changing trends in gastric carcinoma at a university medical center: a twelve-year retrospective analysis. J Clin Gastroenterol 2001;32:37-40. https://doi.org/10.1097/00004836-200101000-00009
  32. Clark GW, Smyrk TC, Burdiles P, Hoeft SF, Peters JH, Kiyabu M, et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994;129:609-614. https://doi.org/10.1001/archsurg.1994.01420300051007
  33. Dolan K, Sutton R, Walker SJ, Morris AI, Campbell F, Williams EM. New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology. Br J Cancer 1999;80:834-842. https://doi.org/10.1038/sj.bjc.6690429
  34. Rudiger Siewert J, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000;232:353-361. https://doi.org/10.1097/00000658-200009000-00007
  35. Kusano C, Gotoda T, Khor CJ, Katai H, Kato H, Taniguchi H, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol 2008;23:1662-1665. https://doi.org/10.1111/j.1440-1746.2008.05572.x
  36. Strong VE, Song KY, Park CH, Jacks LM, Gonen M, Shah M, et al. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg 2010;251:640-646. https://doi.org/10.1097/SLA.0b013e3181d3d29b
  37. Kim HJ, Kwon SJ. Analysis of clinicopathologic difference between type II and type III cancers in Siewert classification for adenocarcinoma of the cardia. J Gastric Cancer 2004;3:143- 148
  38. Jang JH, Beron RI, Ahn HS, Kong SH, Lee HJ, Kim WH, et al. Clinicopathological features of upper third gastric cancer during a 21-year period (single center analysis). J Gastric Cancer 2010;10:212-218. https://doi.org/10.5230/jgc.2010.10.4.212
  39. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. Published online: 15 May 2011.
  40. Rausei S, Dionigi G, Boni L, Rovera F, Dionigi R. How does the 7th TNM edition fit in gastric cancer management? Ann Surg Oncol 2010 Sep 29. [Epub ahead of print].

Cited by

  1. Cost of Illness in Colorectal Cancer: An International Review vol.31, pp.7, 2011, https://doi.org/10.1007/s40273-013-0055-4
  2. Comparison of Laparoscopy-Assisted and Totally Laparoscopic Distal Gastrectomy: The Short-Term Outcome at a Low Volume Center vol.13, pp.1, 2011, https://doi.org/10.5230/jgc.2013.13.1.44
  3. Different expression pattern and significance of p14ARF-Mdm2-p53 pathway and Bmi-1 exist between gastric cardia and distal gastric adenocarcinoma vol.44, pp.5, 2011, https://doi.org/10.1016/j.humpath.2012.08.009
  4. Robotic versus Laparoscopic versus Open Gastrectomy: A Meta-Analysis vol.13, pp.3, 2011, https://doi.org/10.5230/jgc.2013.13.3.136
  5. The variant interleukin 1f7 rs3811047 G&gt;A was associated with a decreased risk of gastric cardiac adenocarcinoma in a Chinese Han population vol.35, pp.4, 2014, https://doi.org/10.1007/s13277-013-1463-y
  6. Differential expression of Pim-3, c-Myc, and p-p27 proteins in adenocarcinomas of the gastric cardia and distal stomach vol.35, pp.5, 2014, https://doi.org/10.1007/s13277-014-1664-z
  7. Evaluation of the seventh AJCC TNM staging system for gastric cancer: a meta-analysis of cohort studies vol.35, pp.9, 2011, https://doi.org/10.1007/s13277-014-1848-6
  8. Decreased expression of eukaryotic initiation factor 3f is an adverse prognostic factor for stage I–III gastric cancer vol.12, pp.None, 2011, https://doi.org/10.1186/1477-7819-12-72
  9. Interleukin 17A rs3819024 A>G polymorphism is associated with an increased risk of gastric cardia adenocarcinoma in a Chinese population vol.19, pp.5, 2014, https://doi.org/10.3109/1354750x.2014.924158
  10. PET/CT predicts survival in patients undergoing primary surgery for esophageal cancer vol.400, pp.2, 2011, https://doi.org/10.1007/s00423-014-1264-9
  11. Incorporating Surgical Quality into the AJCC 7th Edition Improves Staging Accuracy in Gastric Cancer vol.22, pp.1, 2011, https://doi.org/10.1245/s10434-014-4004-z
  12. N3 Subclassification Incorporated into the Final Pathologic Staging of Gastric Cancer : A Modified System Based on Current AJCC Staging vol.94, pp.8, 2011, https://doi.org/10.1097/md.0000000000000575
  13. Interleukin 12B rs3212227 T > G polymorphism was associated with an increased risk of gastric cardiac adenocarcinoma in a Chinese population vol.28, pp.3, 2011, https://doi.org/10.1111/dote.12189
  14. Clinicopathologic Implications of Eukaryotic Initiation Factor 3f and Her-2/neu Expression in Gastric Cancer : Cheng et al. n eIF3f Related with Prognosis of Gastric Cancer vol.8, pp.4, 2011, https://doi.org/10.1111/cts.12263
  15. Comparison of Different Methods of Multislice Spiral Computed Tomography for the Preoperative Gastric Cancer Staging vol.6, pp.9, 2011, https://doi.org/10.4236/ss.2015.69061
  16. Cachexia‐associated adipose tissue morphological rearrangement in gastrointestinal cancer patients vol.7, pp.1, 2011, https://doi.org/10.1002/jcsm.12037
  17. Flow cytometry as the new ‘gold standard’ for detection of free tumour cells in abdominal lavage fluid in gastric cancer patients: A comparative study of molecular and conventional methods vol.20, pp.2, 2011, https://doi.org/10.1111/1744-1633.12173
  18. Decreased RNA-binding motif 5 expression is associated with tumor progression in gastric cancer vol.39, pp.3, 2017, https://doi.org/10.1177/1010428317694547
  19. Proinflammatory follicular helper T cells promote immunoglobulin G secretion, suppress regulatory B cell development, and correlate with worse clinical outcomes in gastric cancer vol.39, pp.6, 2011, https://doi.org/10.1177/1010428317705747
  20. High expression of eIF3d is associated with poor prognosis in patients with gastric cancer vol.9, pp.None, 2011, https://doi.org/10.2147/cmar.s142324
  21. Early suppression of adipocyte lipid turnover induces immunometabolic modulation in cancer cachexia syndrome vol.31, pp.5, 2011, https://doi.org/10.1096/fj.201601151r
  22. MicroRNA-455 is downregulated in gastric cancer and inhibits cell proliferation, migration and invasion via targeting insulin-like growth factor 1 receptor vol.16, pp.3, 2017, https://doi.org/10.3892/mmr.2017.6979
  23. Impact of peri-operative blood transfusion on post-operative infections after radical gastrectomy for gastric cancer: a propensity score matching analysis focusing on the timing, amount of transfusion vol.144, pp.6, 2011, https://doi.org/10.1007/s00432-018-2630-8
  24. Changes in blood glucose of elderly patients with gastric cancer combined with type 2 diabetes mellitus after radical operation and the effect of mediation adjustment for blood glucose on the recovery vol.16, pp.4, 2011, https://doi.org/10.3892/ol.2018.9197
  25. SURGICAL TREATMENT OF GASTRIC ADENOCARCINOMA: TOTAL VS. SUBTOTAL GASTRECTOMY. A SINGLE CENTRE EXPERIENCE vol.87, pp.2, 2018, https://doi.org/10.31482/mmsl.2018.013
  26. Incidence, Causes and Risk Factors for 30-Day Unplanned Reoperation After Gastrectomy for Gastric Cancer: Experience of a High-Volume Center vol.11, pp.3, 2011, https://doi.org/10.14740/gr1032w
  27. National Trend in Laparoscopic Gastrectomy for Gastric Cancer: Analysis of the National Register in Chile vol.35, pp.5, 2011, https://doi.org/10.1159/000485197
  28. Peri-Operative Blood Transfusion Does Not Influence Overall and Disease-Free Survival After Radical Gastrectomy for Stage II/III Gastric Cancer: a Propensity Score Matching Analysis vol.22, pp.9, 2011, https://doi.org/10.1007/s11605-018-3808-8
  29. Retrospective study on recovery of 521 gastrointestinal tumor patients after laparoscopic surgery vol.16, pp.3, 2011, https://doi.org/10.3892/ol.2018.9064
  30. Incidence, causes and risk factors for 30-day readmission after radical gastrectomy for gastric cancer: a retrospective study of 2,023 patients vol.8, pp.None, 2018, https://doi.org/10.1038/s41598-018-28850-8
  31. Prealbumin and lymphocyte-based prognostic score, a new tool for predicting long-term survival after curative resection of stage II/III gastric cancer vol.120, pp.12, 2011, https://doi.org/10.1017/s0007114518002854
  32. Clinicopathological features and prognosis of young gastric cancer patients following radical gastrectomy: a propensity score matching analysis vol.9, pp.None, 2011, https://doi.org/10.1038/s41598-019-42406-4
  33. Role of Multidetector CT in Staging of Gastric Carcinoma vol.10, pp.7, 2019, https://doi.org/10.4236/jct.2019.107046
  34. Multi‐institutional validation of the 8th AJCC TNM staging system for gastric cancer: Analysis of survival data from high‐volume Eastern centers and the SEER database vol.120, pp.4, 2011, https://doi.org/10.1002/jso.25639
  35. Prophylactic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer-A Systematic Review vol.8, pp.10, 2011, https://doi.org/10.3390/jcm8101685
  36. Changing trends of clinicopathologic features and survival duration after surgery for gastric cancer in Northeast China vol.12, pp.10, 2020, https://doi.org/10.4251/wjgo.v12.i10.1119
  37. Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial vol.13, pp.18, 2011, https://doi.org/10.3390/cancers13184626
  38. 18F-fluorodeoxyglucose uptake in advanced gastric cancer correlates with histopathological subtypes and volume of tumor stroma vol.145, pp.None, 2011, https://doi.org/10.1016/j.ejrad.2021.110048